Scarica l'app Stockscreener
9.07
2.47%
-0.23
Dopo l'orario di chiusura:
8.93
-0.14
-1.54%
Precedente Chiudi:
$9.30
Aprire:
$9.3
Volume 24 ore:
966.45K
Relative Volume:
0.83
Capitalizzazione di mercato:
$509.15M
Reddito:
$27.46M
Utile/perdita netta:
$-46.05M
Rapporto P/E:
-7.031
EPS:
-1.29
Flusso di cassa netto:
$-33.83M
1 W Prestazione:
-3.92%
1M Prestazione:
-16.10%
6M Prestazione:
+16.43%
1 anno Prestazione:
+22.73%
Intervallo 1D:
$8.97
$9.39
Intervallo di 1 settimana:
$8.97
$9.48
Portata 52W:
$6.19
$13.16
Zevra Therapeutics Inc Stock (ZVRA) Company Profile
Nome
Zevra Therapeutics Inc
Settore
Industria
Telefono
(321) 939-3416
Indirizzo
1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION
Confronta ZVRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZVRA
Zevra Therapeutics Inc
|
9.07 | 522.06M | 27.46M | -46.05M | -33.83M | -1.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Zevra Therapeutics Inc Stock (ZVRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-01-08 | Ripresa | Cantor Fitzgerald | Overweight |
| 2024-10-07 | Iniziato | Guggenheim | Buy |
| 2024-09-24 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-09-24 | Reiterato | Maxim Group | Buy |
| 2024-04-02 | Reiterato | Maxim Group | Buy |
| 2024-03-12 | Iniziato | William Blair | Outperform |
| 2023-03-17 | Iniziato | Maxim Group | Buy |
Mostra tutto
Zevra Therapeutics Inc Borsa (ZVRA) Ultime notizie
Is Zevra Therapeutics Inc. still worth holding after the dipStop Loss & Long-Term Growth Stock Strategies - Newser
Analyzing drawdowns of Zevra Therapeutics Inc. with statistical toolsWeekly Trade Review & AI Driven Price Predictions - Newser
Is Zevra Therapeutics Inc. stock showing strong momentumEarnings Growth Summary & Growth Focused Stock Pick Reports - خودرو بانک
Favourable Signals For Zevra Therapeutics: Numerous Insiders Acquired Stock - Yahoo Finance
Custom strategy builders for tracking Zevra Therapeutics Inc.2025 Market Sentiment & Weekly Watchlist for Hot Stocks - Newser
How to manage a losing position in Zevra Therapeutics Inc.July 2025 Recap & Verified Swing Trading Watchlist - Newser
Is now a turning point for Zevra Therapeutics Inc.2025 Market Sentiment & Free Real-Time Market Sentiment Alerts - Newser
Advanced analytics toolkit walkthrough for Zevra Therapeutics Inc.Share Buyback & Real-Time Volume Spike Alerts - Newser
What makes Zevra Therapeutics Inc. stock price move sharplyPortfolio Profit Report & Expert Verified Stock Movement Alerts - Newser
Relative strength of Zevra Therapeutics Inc. in sector analysisJuly 2025 News Drivers & Free High Accuracy Swing Entry Alerts - Newser
What recovery options are there for Zevra Therapeutics Inc.July 2025 Macro Moves & High Conviction Buy Zone Alerts - Newser
Zevra Therapeutics Inc. stock retracement – recovery analysisVolume Spike & Real-Time Price Movement Reports - Newser
How to build a dashboard for Zevra Therapeutics Inc. stockJobs Report & Accurate Technical Buy Alerts - Newser
Does Zevra Therapeutics Inc. qualify in momentum factor screening2025 Bull vs Bear & Growth Focused Entry Point Reports - Newser
Risk adjusted return profile for Zevra Therapeutics Inc. analyzedWeekly Investment Recap & Weekly Return Optimization Plans - Newser
Is It Too Early to Call Recovery in Zevra Therapeutics Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Zevra Therapeutics Faces $58.7 Million Impairment Charge, Raising Concerns Over Financial Stability - MSN
Is Zevra Therapeutics Inc. stock bottoming outPortfolio Gains Summary & Growth Focused Entry Point Reports - Newser
Tools to monitor Zevra Therapeutics Inc. recovery probabilityPortfolio Gains Summary & Advanced Technical Analysis Signals - Newser
Will earnings trigger a reversal in Zevra Therapeutics Inc2025 Analyst Calls & Momentum Based Trading Signals - Newser
Is Zevra Therapeutics Inc. stock overhyped or has real potentialJuly 2025 Momentum & Low Risk Investment Opportunities - Newser
Price Consolidation Hints at Upcoming Move in Zevra Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Zevra Therapeutics to Present Award-Winning MIPLYFFA Data at International Metabolic Disorders Conference - citybuzz -
Zevra Therapeutics Inc Azioni (ZVRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Zevra Therapeutics Inc Azioni (ZVRA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Thompson Rahsaan | Chief Legal & Compliance |
Jun 26 '25 |
Sale |
9.21 |
24,000 |
221,004 |
42,666 |
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):